Mother and Late Preterm Lactation Study (MAPLeS)

July 18, 2022 updated by: University College, London

A Randomised Controlled Trial Testing the Use of a Simple Intervention on Maternal Psychological State, Breast Milk Composition and Volume, and Infant Behaviour and Growth.

Breastfeeding has various benefits for the mother and infant. It has the capability of reducing the risk of short term and long term problems for the infant, such as gastroenteritis, respiratory infections, type II diabetes and obesity, and of providing benefits for neurodevelopment. Breast milk offers even greater benefits for preterm infants. Some of the advantages of breastfeeding are related to the constituents of breast milk such as the macronutrients and bioactive factors, the hormones associated with breastfeeding such as oxytocin, and the behavioural aspects of breastfeeding (maternal sensitivity to infant cues). Despite these advantages, breastfeeding rates are below target levels mainly due to the challenges that women face that hinder breastfeeding success. Interventions aimed at improving policies, practices, and maternal support have been developed. However, other interventions that target specific modifiable barriers to breastfeeding can be useful.

The aim of this study is to investigate a simple support intervention for breastfeeding mothers of late preterm and early term infants on maternal stress reduction and infant weight gain. The investigators also aim to study the potential mechanisms by which this effect could be achieved (breast milk composition and volume, mother and infant behaviour).

Study Overview

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Mothers of late preterm infants (34 to <37 weeks) or early term infants (37 to 38 weeks)
  • Intending to breastfeed for at least 6 weeks
  • Free from serious illness
  • Fluent in English

Exclusion Criteria:

  • Currently smoking or intending to smoke while breastfeeding
  • Not based in London
  • Prior breast surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Breastfeeding Support
Home visits will be conducted at 2-3 and 6-8 weeks post-delivery. Mothers will be asked to perform a simple technique while breastfeeding at least once a day.
12-minute simple technique
No Intervention: Standard Care
Home visits will be conducted at 2-3 and 6-8 weeks post-delivery. No intervention will be administered.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal stress change at 6 weeks from 2 weeks post-delivery.
Time Frame: Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Stress will be measured using the Perceived Stress Scale (0 to 40 points), where higher scores indicate a higher level of perceived stress.
Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Infant weight change at 6 weeks from 2 weeks post-delivery.
Time Frame: Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Infant weight (kg) will be measured using an infant weighing scale.
Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breast milk composition (macronutrients) change at 6 weeks from 2 weeks post-delivery.
Time Frame: Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Breast milk samples will be collected at 2 and 6 weeks post-delivery. Fat, protein and carbohydrate content of breast milk (g/100 ml) will be analysed using the Miris- Human Milk Analyser.
Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Breast milk hormones change at 6 weeks from 2 weeks post-delivery.
Time Frame: Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Breast milk samples will be collected at 2 and 6 weeks post-delivery. Ghrelin, leptin, adiponectin and cortisol will be analysed (ng/ml) using the respective ELISA kits.
Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Breast milk volume change at 6 weeks from 2 weeks post-delivery.
Time Frame: Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Breast milk volume (ml) will be assessed using 48-hour test weighing
Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Infant behaviour change at 6 weeks from 2 weeks post-delivery.
Time Frame: Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Time spent crying and sleeping (minutes) will be measured using a 3-day behaviour diary
Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Infant appetite change at 6 weeks from 2 weeks post-delivery.
Time Frame: Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Infant appetite will be assessed using the Baby Eating Behaviour Questionnaire, with the following subscales (appetite traits): General Appetite (1 to 5 points), Enjoyment of Food (1 to 5 points), Satiety Responsiveness (1 to 5 points), Food Responsiveness (1 to 5 points), and Slowness in Eating (1 to 5 points). Higher scores on each subscale indicates a greater degree of the appetite trait.
Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Mother-infant attachment change at 6 weeks from 2 weeks post-delivery.
Time Frame: Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
The extent of bonding between the mother and infant will be assessed using the Maternal Attachment Inventory (0-78 points)
Home visit 1 (2 weeks postnatally) and Home visit 2 (6 weeks postnatally)
Exclusive Breastfeeding Status
Time Frame: 6 weeks, 3 months and 6 months postnatally
Participants will be asked whether they are still exclusively breastfeeding their infants at 6 weeks, 3 months and 6 months postnatally to assess breastfeeding status.
6 weeks, 3 months and 6 months postnatally

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 25, 2019

Primary Completion (Actual)

January 13, 2021

Study Completion (Actual)

March 13, 2021

Study Registration Dates

First Submitted

December 27, 2018

First Submitted That Met QC Criteria

January 2, 2019

First Posted (Actual)

January 3, 2019

Study Record Updates

Last Update Posted (Actual)

July 19, 2022

Last Update Submitted That Met QC Criteria

July 18, 2022

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress, Psychological

Clinical Trials on Breastfeeding Support

3
Subscribe